IP Library › Assignment 055857/0001
Patent Assignment
Reel/Frame 055857/0001

Assignment of Assignor's Interest

Recorded: 2021-04-07 Pages: 19
Assignor
RETINAGENIX THERAPEUTICS, INC.
Executed: 2021-01-29
Assignee
RETINAGENIX HOLDINGS LLC
421 KIPLING STREET, PALO ALTO, CALIFORNIA, 94301
Covered Properties (11)
Pharmaceutical Formulations Comprising 9-Cis-Retinyl Esters in a Lipid Vehicle
Application: 61/242,741 →
Pharmaceutical Formulations Comprising 9-Cis-Retinyl Esters in a Lipid Vehicle
Application: 15/274,257 →
Publication: US 2017/0007565
Pharmaceutical Formulations Comprising 9-Cis-Retinyl Esters in a Lipid Vehicle
Application: 16/158,738 →
Publication: US 2019/0183835
Methods for Treating Visual Disorders Associated with Endogenous Retinoid Deficiency
Application: 61/325,763 →
Methods for Treating Visual Disorders Associated with Endogenous Retinoid Deficiency
Application: 61/407,436 →
Methods for Treating Visual Disorders Associated with Endogenous Retinoid Deficiency
Application: 61/447,611 →
Therapeutic Regimen and Methods for Treating or Ameliorating Visual Disorders Associated with an Endogenous Retinoid Deficiency
Patent: 9,173,856 →
Application: 13/090,215 →
Publication: US 2011/0257266
Therapeutic Regimen and Methods for Treating or Ameliorating Visual Disorders Associated with an Endogenous Retinoid Deficiency
Patent: 9,987,245 →
Application: 14/875,342 →
Publication: US 2017/0087114
Therapeutic Regimen and Methods for Treating or Ameliorating Visual Disorders Associated with an Endogenous Retinoid Deficiency
Application: 15/968,358 →
Publication: US 2019/0029986
Therapeutic Regimens and Methods for Improving Visual Function in Visual Disorders Associated with an Endogenous Retinoid Deficiency
Application: 16/005,155 →
Publication: US 2019/0054039
Pharmaceutical Formulations Comprising 9-Cis-Retinyl Esters in a Lipid Vehicle
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 2, 2010
From: BOCH, RONALD ERWIN
To: QLT INC
Reel/Frame 023887/0885 →
Assignment of Assignor's Interest Jul 6, 2011
From: STRONG, H ANDREW; CADDEN, SUZANNE
To: QLT INC.
Reel/Frame 026547/0599 →
Assignment of Assignor's Interest Oct 25, 2011
From: STRONG, H ANDREW
To: QLT INC.
Reel/Frame 027112/0463 →
Assignment of Assignor's Interest Oct 25, 2011
From: STRONG, H ANDREW
To: QLT INC.
Reel/Frame 027112/0644 →
Change of Name May 4, 2017
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 042245/0563 →
Assignment of Assignor's Interest May 4, 2017
From: STRONG, H. ANDREW; CADDEN, SUZANNE
To: QLT INC.
Reel/Frame 042245/0425 →
Change of Name May 4, 2017
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 042246/0375 →
Assignment of Assignor's Interest May 4, 2017
From: BOCH, RONALD ERWIN
To: QLT INC.
Reel/Frame 042243/0666 →
Change of Name May 4, 2017
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 042243/0830 →
Assignment of Assignor's Interest Feb 20, 2019
From: BOCH, RONALD ERWIN
To: QLT INC.
Reel/Frame 048383/0260 →
Assignment of Assignor's Interest Feb 20, 2019
From: CADDEN, SUZANNE
To: QLT INC.
Reel/Frame 048383/0469 →
Assignment of Assignor's Interest Feb 20, 2019
From: STRONG, H. ANDREW; CADDEN, SUZANNE
To: QLT INC.
Reel/Frame 048383/0396 →
Change of Name Feb 20, 2019
From: QLT INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 048383/0577 →
Assignment of Assignor's Interest Feb 21, 2019
From: NOVELION THERAPEUTICS INC.
To: RETINAGENIX, LLC
Reel/Frame 048403/0004 →
Assignment of Assignor's Interest Mar 20, 2020
From: RETINAGENIX, LLC
To: RETINAGENIX THERAPEUTICS, INC.
Reel/Frame 052175/0176 →
Assignment of Assignor's Interest Aug 9, 2022
From: RETINAGENIX HOLDINGS LLC
To: ELUMINEX BIOSCIENCES (SUZHOU) LIMITED
Reel/Frame 060763/0001 →